Sequential therapy with crizotinib and a second-generation ALK inhibitor versus direct therapy of a second-generation ALK inhibitor in ALK-positive advanced lung cancer: a real-world study - Wei, Jingwen; Zhou, Huan; Song, Zhengbo (Journal of Thoracic Disease; Vol 15, No 5 (May 30, 2023): Journal of Thoracic Disease, 2023)